Zoledronic acid blocks the interaction between breast cancer cells and regulatory T-cells

Zoledronic acid (ZA), a nitrogen-containing bisphosphonate, inhibits osteoclastogenesis. Emerging evidence suggests that ZA has anti-tumor and anti-metastatic properties for breast cancer cells. In a mouse mod...

Source: BMC Cancer - February 26, 2019 Category: Cancer & Oncology Authors: Hsien Liu, Shih-Han Wang, Shin-Cheh Chen, Ching-Ying Chen and Tsun-Mei Lin Tags: Research article Source Type: research